Transcripts

Kyverna Therapeutics (KYTX) earnings call transcripts

Earnings call transcripts for Kyverna Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

Open KYTX in Gloom →
Kyverna Therapeutics' chart, financials and news, free in your browser.Open KYTX in Gloom →
  • trial results, September 23, 2026

    Management framed the one-year data as strengthening MIF-CEL’s durability, safety, and regulatory case while keeping commercial readiness on track.

    Sep 24, 2026Confident0.86
  • conference, September 14, 2026

    Management framed Kyverna as advancing a differentiated autoimmune CAR-T platform, with SPS filing and launch preparation the near-term priority.

    Sep 14, 2026Confident0.72